The FDA Has Made Caffeine Labeling a Priority
By
Published
Filed under

By
Published
Filed under

It would seem that the powers that be at the Food and Drug Administration (FDA) are going after some gas station cowboy favorites.
Earlier this year, the FDA took steps to recommend scheduling 7-hydroxymitragynine (7-OH), an opiate-like compound derived from kratom and freely sold in gas stations and head shops. Now, the FDA has set its eyes on caffeinated food and drinks. Recently, the agency announced that it would draft new guidance for caffeine labeling. FDA guidance documents communicate the agency’s position and thinking and don’t necessarily impose rules. However, that guidance could serve as a dowsing rod to know the federal government’s regulatory priorities and what other agencies may do.
Get unlimited access to latest industry news, 27,000+ articles and case studies.
Have an account? Sign in